Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps

World J Gastroenterol. 2006 Mar 7;12(9):1468-71. doi: 10.3748/wjg.v12.i9.1468.

Abstract

Aim: To detect the expression of pituitary adenylate cyclase-activating polypeptide receptor 1 (VPCAP1-R)and VPCAP2-R mRNA in gallbladder tissues of patients with gallstone or gallbladder polyps.

Methods: The expression of VPCAP1-R and VPCAP2-R mRNA in gallbladder tissues was detected in 25 patients with gallstone,8 patients with gallbladder polyps and 7 donors of liver transplantation by reverse transcription polymerase chain reaction (RT-PCR).

Results: The VPCAP2-R mRNA expression level in the control group (1.09+/-0.58) was lower than that in the gallbladder polyp group (1.64+/-0.56) and the gallstone group (1.55+/-0.45) (P<0.05) while the VPCAP1-R mRNA expression level in the control group (1.15+/-0.23) was not apparently different from that in the gallbladder polyp group (1.28+/-0.56) and the gallstone group (1.27+/-0.38).

Conclusion: The abnormal expression of VPCAP2-R mRNA in gallbladder tissue may play a role in the formation of gallbladder stone and gallbladder polyps.

MeSH terms

  • Adult
  • Female
  • Gallbladder / chemistry*
  • Gallbladder Diseases / genetics*
  • Gallbladder Diseases / metabolism
  • Gallstones / chemistry
  • Gallstones / etiology
  • Gallstones / genetics*
  • Gene Expression Regulation
  • Humans
  • Male
  • Middle Aged
  • Polyps / chemistry
  • Polyps / etiology
  • Polyps / genetics*
  • RNA, Messenger / analysis*
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / genetics*
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / physiology
  • Receptors, Vasoactive Intestinal Polypeptide, Type I / genetics*
  • Receptors, Vasoactive Intestinal Polypeptide, Type I / physiology
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • RNA, Messenger
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • Receptors, Vasoactive Intestinal Polypeptide, Type I